Dark

PCRX
Pacira BioSciences, Inc. Common Stock
stock NASDAQ

At Close

Jan 30, 2026 3:59:48 PM EST

20.55USD+2.290%(+0.46)496,745

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jan 27, 2026 9:03:30 AM EST

20.61USD+2.588%(+0.52)0

After-hours

Jan 30, 2026 4:00:30 PM EST

20.54USD-0.049%(-0.01)12,829

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

844.61M

CEO

David M. Stack

Headquarters

Parsippany, New Jersey, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Feb 26, 2026 (25d)

DRRX BDSI CPIX ABC REPH CARA FLXN HRTX XLV

PCRX Stats

Avg. Vol. 10 Day

954,905

Avg. Vol. 30 Day

981,686

Employees

489

Market Cap

844,605,000

Shares Out.

41,100,000

On/Off Exchange

57%/43%

6 Month Beta

0.49

1 Year Beta

0.24

2 Year Beta

0.27

3 Year Beta

0.40

52 Week Low

18.80

52 Week High

27.64

SMA50

23.76

SMA200

24.26

1 Week

-0.58%

1 Month

-20.60%

3 Month

-3.88%

6 Month

-2.56%

1 Year

-21.95%

2 Year

-36.94%

5 Year

-70.63%

Profile

pacira pharmaceuticals, inc. (nasdaq: pcrx) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. the company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, exparel® (bupivacaine liposome injectable suspension), was commercially launched in the united states in april 2012. exparel and two other products have utilized the pacira proprietary product delivery technology depofoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time.

PCRX Stock Summary

Pacira BioSciences, Inc. Common Stock (NASDAQ:PCRX) stock price today is $20.55, and today's volume is 496,745. PCRX is up 2.290% today. The 30 day average volume is 981,686. PCRX market cap is 844.61M with 41,100,000 shares outstanding.